Savvy Extras, 6/21/22: From DiabetesMine D-Data Exchange 2022
DiabetesMine D-Data is an extraordinary semi-annual event that showcases significant and unique topics in diabetes technology and management, hosted by founder/T1D Amy Tenderich. This year’s virtual was, as always, informative, educational, and exciting to...
Savvy Updates 6/20/22: Study to Regenerate Beta Cells, Senseonics Eversense E3 180-day CGM Gets CE Mark, Piezoelectric Button to Control T1D, Insulin & Weight Gain, Lager Beer Improves Gut Health, Best Time to Exercise Differs by Sex, Recession Impact on Medical Device Growth
New potential diabetes treatment regenerates insulin-producing cells was written by Michael Irving for NewAtlas.com, 13 June 2022. An emerging way to treat diabetes is to repair or replace the cells in the body that naturally produce insulin. Swedish researchers have...
Savvy Hot News, 6/17/22: FTC votes unanimously to increase scrutiny over PBMs ~ FOCUS on INSULIN!
FTC votes unanimously to increase scrutiny over pharmacy agent fees was reported by Dulan Lokuwithana for SeekingAlpha.com, 16 June 2022. The Federal Trade Commission (FTC) voted unanimously to adopt a policy statement stating its intention to more closely examine the...
Savvy Updates 6/13/22: Dexcom vs. Abbott, CREATE Trial: DIY Insulin Delivery System Safe, Effective, Gluroo App
Dexcom and Abbott’s fight over glucose monitoring patents intensifies in Europe was posted by Amy Sandys for Juve-Patent.com, 20 May 2022. Dexcom and Abbott are currently going head-to-head over twelve separate patents covering their respective glucose monitoring...
Savvy Updates 6/8/22: More on Dexcom, CGM Accuracy Study, CGM Alarm Fatigue, Prior Authorizations Reform (NOT)
More on Dexcom: Dexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans was published by Ricky Zipp for MedTechDive.com, 7 June 2022. The executive spoke about the company’s discussions with the FDA on the G7 CGM system,...
More Diabetes Blogs